Acceleron Pharma Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was USD 34.2 million compared to USD 22.56 million a year ago. Net loss was USD 70.47 million compared to USD 39.25 million a year ago. Basic loss per share from continuing operations was USD 1.16 compared to USD 0.66 a year ago. For the nine months, revenue was USD 86.9 million compared to USD 66.66 million a year ago. Net loss was USD 197.46 million compared to USD 108.64 million a year ago. Basic loss per share from continuing operations was USD 3.25 compared to USD 1.95 a year ago.